Smith & Nephew plc (SNNUF)
OTCMKTS · Delayed Price · Currency is USD
17.50
0.00 (0.00%)
Feb 10, 2026, 9:30 AM EST
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of $14.88 billion as of February 11, 2026. Its market cap has increased by 34.21% in one year.
Market Cap
14.88B
Enterprise Value
17.64B
Revenue
5.94B
Ranking
n/a
PE Ratio
30.30
Stock Price
$17.50
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 1.18B to 14.88B, an increase of 1,155.60%. That is a compound annual growth rate of 6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 14.95B | 5.55% |
| Dec 31, 2025 | 14.16B | 30.86% |
| Dec 31, 2024 | 10.82B | -9.46% |
| Dec 29, 2023 | 11.95B | 2.84% |
| Dec 30, 2022 | 11.62B | -24.46% |
| Dec 31, 2021 | 15.39B | -14.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Positron | 58.27M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |